These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Aluminum concentrations in drinking water and risk of Alzheimer's disease. Martyn CN; Coggon DN; Inskip H; Lacey RF; Young WF Epidemiology; 1997 May; 8(3):281-6. PubMed ID: 9115023 [TBL] [Abstract][Full Text] [Related]
27. Aluminum and Alzheimer's disease, a personal perspective after 25 years. Perl DP; Moalem S J Alzheimers Dis; 2006; 9(3 Suppl):291-300. PubMed ID: 17004365 [TBL] [Abstract][Full Text] [Related]
28. Aluminum, parathyroid hormone, and osteomalacia. Burnatowska-Hledin MA; Kaiser L; Mayor GH Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572 [TBL] [Abstract][Full Text] [Related]
29. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. Walton JR J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457 [TBL] [Abstract][Full Text] [Related]
31. Aluminum: a possible neurotoxic agent in Alzheimer's disease. Crapper DR; Krishnan SS; De Boni U; Tomko GJ Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624 [No Abstract] [Full Text] [Related]
32. Neurofibrillary pathology and aluminum in Alzheimer's disease. Shin RW; Lee VM; Trojanowski JQ Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes. MacDonald AB Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667 [TBL] [Abstract][Full Text] [Related]
34. Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy. Reusche E Acta Neuropathol; 1997 Dec; 94(6):612-6. PubMed ID: 9444364 [TBL] [Abstract][Full Text] [Related]
36. Is there any relationship between aluminum and Alzheimer's disease? Eichhorn GL Exp Gerontol; 1993; 28(4-5):493-8. PubMed ID: 8224045 [TBL] [Abstract][Full Text] [Related]
37. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease. Savory J; Huang Y; Wills MR; Herman MM Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957 [TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Perl DP; Brody AR Science; 1980 Apr; 208(4441):297-9. PubMed ID: 7367858 [TBL] [Abstract][Full Text] [Related]
39. Aluminum determination in whole blood, dialysis solution, and tap water samples from Maracaibo dialysis units (Venezuela) by graphite furnace atomic absorption spectrometry. Navarro JA; Parra OE; Romero RA J Trace Elem Electrolytes Health Dis; 1988 Mar; 2(1):3-8. PubMed ID: 2980789 [TBL] [Abstract][Full Text] [Related]
40. Aluminium and the neurofibrillary tangle: results of tissue microprobe studies. Perl DP; Good PF Ciba Found Symp; 1992; 169():217-27; discussion 227-36. PubMed ID: 1490424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]